title: Improving access to FDA reviews and documents.
authors.forename: Donald A
authors.initials: DA
authors.lastname: Tuttle
authors.forename: Larry D
authors.initials: LD
authors.lastname: Sasich
authors.forename: Sana R
authors.initials: SR
authors.lastname: Sukkari
mesh_terms: D002986:Clinical Trials as Topic; D017277:Drug Approval; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D033181:Information Dissemination; D010080:Oxazoles / Q000009:adverse effects; D017712:Peer Review, Research; D047492:Peroxisome Proliferator-Activated Receptors / Q000819:agonists; D017594:Publication Bias; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D010080:Oxazoles; D047492:Peroxisome Proliferator-Activated Receptors; D005998:Glycine; C500085:muraglitazar